• LG 101506 for RXR Signaling Research

  2026-08-25

  LG 101506 provides a controllable small-molecule entry point for RXR signaling pathway research, with practical workflows spanning nuclear receptor assays, metabolism regulation, and tumor-immunology hypothesis testing. This guide emphasizes dose planning, matched controls, orthogonal readouts, and the limits of translating RBMS1–PD-L1 findings into RXR experiments.

• Verapamil HCl: A Txnip-Centered Research Framework

  2026-08-25

  Verapamil HCl is an L-type calcium channel blocker with applications that extend from calcium signaling to bone-remodeling research. This guide explains how to distinguish direct channel effects from Txnip-associated pathway changes and design better translational assays.

• PRINT: RNA-Mediated Safe-Harbor Transgene Insertion

  2026-08-24

  The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to insert transgenes at a multicopy human safe-harbor locus through target-primed reverse transcription. Its results show substantial insertion frequencies in cultured human primary cells while avoiding donor DNA, although locus specificity, junction integrity, delivery, and long-term safety require further validation.

• Topotecan Workflow for DNA Damage Research

  2026-08-24

  Build more reproducible Topotecan experiments by connecting concentration selection, time-resolved DNA damage measurements, apoptosis endpoints, and practical formulation controls. The workflow also shows how a radiotracer biodistribution study can inspire better assay controls without overstating evidence across disease areas.

• Dovitinib and ERK: Designing Better Cancer Assays

  2026-08-23

  Dovitinib (TKI-258) offers a powerful way to interrogate receptor tyrosine kinase and downstream ERK–STAT signaling in cancer models. This article connects its multitarget profile with IFNγ-driven melanoma apoptosis to improve mechanistic assay design beyond simple viability measurements.

• Sabutoclax Workflows for Apoptosis Assays

  2026-08-22

  Sabutoclax is a membrane-permeable pan-Bcl-2 inhibitor for dissecting anti-apoptotic dependence across cancer models. This guide connects concentration-response testing with separate measurements of growth inhibition and cell killing, improving interpretation in vitro and during xenograft translation.

• PreScission Protease for Nuclear Protein Workflows

  2026-08-21

  PreScission Protease combines sequence-defined HRV 3C protease activity with low-temperature processing for cleaner fusion-tag removal. This article translates that capability into practical workflows for soluble recombinant proteins, dKeap1–lamin Dm0 interaction studies, and troubleshooting-sensitive nuclear assays.

• NSC 87877: Reliable Shp2 Inhibitor Workflows

  2026-08-20

  Learn how NSC 87877 (SKU A4544) can support reproducible Shp2 pathway experiments, from EGF-induced Erk1/2 signaling to viability and cytotoxicity assays. This scenario-based guide separates biochemical potency from cellular response and provides practical formulation, storage, and vendor-selection guidance.

• M344: Practical HDAC Inhibitor Workflows

  2026-08-20

  M344 is a cell-permeable histone deacetylase inhibitor for linking chromatin acetylation to proliferation, differentiation, apoptosis, radiation response, and viral latency. This workflow-focused guide covers dose selection, assay controls, solubility, model-specific applications, and troubleshooting for reproducible in vitro and ex vivo studies.

• Alfuzosin HCl: From Receptor Signal to Assay

  2026-08-19

  Explore how Alfuzosin HCl links α1-adrenergic pharmacology with gastroretentive formulation science and assay design. This evidence-led guide translates MRI-verified gastric retention into practical decisions for benign prostatic hyperplasia research.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-19

  The reference study identifies protein phosphatase 2A, particularly its PPH21 catalytic subunit, as a regulator of autophagy-linked biofilm formation and antifungal resistance in Candida albicans. By combining PPH21 deletion, rapamycin-mediated autophagy activation, molecular readouts, and an oral infection mouse model, the work connects Atg13 phosphorylation and Atg1 activation with treatment response.

• ECL Western Blotting Substrate Guide

  2026-08-18

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for chemiluminescent Western blot imaging. It is intended for HRP immunoblots using X-ray film or CCD cameras, not for fluorescent or radioisotopic detection workflows.

• TRAP-1 Reactivates p53Y220C by Induced Proximity

  2026-08-18

  The preprint reports TRAP-1, a chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4 and restores transcription of p53-responsive genes. In pancreatic cancer cell models, this mechanism rapidly increased p21 and other target genes while limiting cell growth, highlighting induced proximity as an alternative to simple mutant-protein stabilization.

• Dacomitinib: Designing Mechanism-Resolved Assays

  2026-08-17

  Dacomitinib (PF-00299804) is an irreversible pan-HER inhibitor with a distinctive value in pathway-resolved cancer research. This guide explains how to separate ErbB signaling, apoptosis, cell-cycle arrest, and ferroptosis-related mitochondrial phenotypes when building translational assays.

• Promethazine HCl: Designing Better Immune Assays

  2026-08-17

  Promethazine HCl is more than a histamine H1 antagonist: it is a useful probe for separating receptor pharmacology from ROS-, lysosome-, and autophagy-dependent macrophage responses. This article translates recent phenothiazine research into a rigorous assay-design framework for inflammation research.

465 records 1/31 page Next 12345 下5页 Last page